SAN DIEGO, July 14, 2021–(Organization WIRE)–Robbins Geller Rudman & Dowd LLP announces that purchasers of Ocugen, Inc. (NASDAQ: OCGN) securities amongst February 2, 2021 and
Tag: Ocugen
OCUGEN Trader Detect: Buyers With Considerable Losses Have Opportunity to Direct the Ocugen, Inc. Class Action Lawsuit
SAN DIEGO, July 12, 2021 /PRNewswire/ — The Ocugen, Inc. course motion lawsuit prices Ocugen, Inc. (NASDAQ: OCGN) and certain of its major executives with
Option for Investors With Sizeable Losses to Lead the Ocugen, Inc. Course Motion Lawsuit
SAN DIEGO, July 02, 2021–(Enterprise WIRE)–Robbins Geller Rudman & Dowd LLP announces purchasers of Ocugen, Inc. (NASDAQ:OCGN) securities between February 2, 2021 and June 10,
There’s an Prospect Brewing in Ocugen Inventory, Suggests Analyst
Bloomberg A $6 Trillion Family Business office Planet Fights Write-up-Archegos Crackdown (Bloomberg) — The implosion of Archegos is offering countless numbers of secretive loved ones
Ocugen Provides Business Update and Full Year 2020 Financial Results
Conference Call and Webcast Today at 8:30 a.m. ET COVID-19 vaccine candidate, COVAXIN™, demonstrates efficacy of 81% in Phase 3 interim results Emergency Use Authorization